Beaumont Financial Partners, LLC Abb Vie Inc. Transaction History

Beaumont Financial Partners, LLC

$1.04 Billion
Q3 2022

A detailed history of Beaumont Financial Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Beaumont Financial Partners, LLC holds 10,178 shares of ABBV stock, worth $1.69 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

10,178

Previous 10,202 0.24%

Holding current value

$1.69 Million

Previous $1.56 Million 12.6%

% of portfolio

0.13%

Previous 0.14%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $3,221 - $3,694	-24 Reduced 0.24%	10,178 $1.37 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $27,661 - $35,166	-201 Reduced 1.93%	10,202 $1.56 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $297,746 - $369,420	2,256 Added 27.69%	10,403 $1.69 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $66,284 - $83,868	-617 Reduced 7.04%	8,147 $1.1 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $744 - $845	-7 Reduced 0.08%	8,764 $945,000

Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $83,326 - $92,830	792 Added 9.93%	8,771 $987,000
Q1 2021 May 04, 2021	SELL	$102.3 - $112.62 $45,932 - $50,566	-449 Reduced 5.33%	7,979 $863,000
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $149,469 - $201,800	-1,857 Reduced 18.06%	8,428 $903,000
Q3 2020 Nov 02, 2020	BUY	$85.91 - $100.83 $44,587 - $52,330	519 Added 5.31%	10,285 $901,000
Q2 2020 Aug 05, 2020	BUY	$73.37 - $98.18 $193,036 - $258,311	2,631 Added 36.87%	9,766 $959,000
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $5,934 - $8,996	92 Added 1.31%	7,135 $544,000
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $76,818 - $96,116	1,065 Added 17.82%	7,043 $624,000
Q3 2019 Nov 06, 2019	SELL	$62.98 - $75.72 $49,754 - $59,818	-790 Reduced 11.67%	5,978 $452,000
Q2 2019 Aug 06, 2019	BUY	$65.7 - $83.98 $20,301 - $25,949	309 Added 4.78%	6,768 $492,000
Q1 2019 May 06, 2019	BUY	$77.14 - $90.79 $14,656 - $17,250	190 Added 3.03%	6,459 $521,000
Q3 2018 Nov 02, 2018	SELL	$88.91 - $98.84 $13,069 - $14,529	-147 Reduced 2.29%	6,269 $593,000
Q2 2018 Aug 06, 2018	SELL	$89.78 - $106.23 $53,778 - $63,631	-599 Reduced 8.54%	6,416 $594,000
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $72,871 - $97,582	792 Added 12.73%	7,015 $664,000
Q4 2017 Feb 05, 2018	BUY	$89.56 - $98.21 $53,109 - $58,238	593 Added 10.53%	6,223 $602,000
Q3 2017 Oct 31, 2017	BUY	$69.85 - $89.22 $977 - $1,249	14 Added 0.25%	5,630 $500,000
Q2 2017 Aug 11, 2017	BUY	N/A	5,616	5,616 $407,000

Others Institutions Holding ABBV

# of Institutions

3,654

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $294B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Financial Partners, LLC with notifications on news.

Account

Beaumont Financial Partners, LLC Abb Vie Inc. Transaction History